M&A - Jackson Acquisition Co II

Add to your watchlist
Back to List of Mergers and Acquisitions

Form Type: 10-Q

Filing Date: 2025-05-08

Corporate Action: Acquisition

Type: New

Accession Number: 000121390025041127

Filing Summary: Jackson Acquisition Company II, a blank check company incorporated in the Cayman Islands, filed a quarterly report for the period ending March 31, 2025. The company aims to pursue a business combination primarily in the healthcare sector. As of the filing date, it had not commenced any operations and generated no revenue. The company completed its Initial Public Offering (IPO) on December 11, 2024, raising $230 million. The report includes financial statements showing cash assets of $755,968 and a working capital of $522,736. The company is subject to risk factors, including those arising from geopolitical tensions affecting global markets, which could impact its search for acquisition targets. Additionally, the report describes the redemption rights of shareholders in connection with future business combinations or liquidation events. Jackson Acquisition Company II is classified as an emerging growth company and is managed by RJ Healthcare SPAC II, LLC, underlining its focus on healthcare business acquisitions.

Additional details:

Current Assets: 927900


Cash: 755968


Shareholders Equity: 583542


Net Income: 2227401


Business Combination Focus: healthcare services and technology


Ipo Date: 2024-12-11


Units Offered: 23000000


Ipo Proceeds: 230000000


Working Capital: 522736


Form Type: 10-K

Filing Date: 2025-03-18

Corporate Action: Acquisition

Type: New

Accession Number: 000101376225000620

Filing Summary: Jackson Acquisition Company II is a blank check company incorporated in the Cayman Islands with plans to pursue mergers and business combinations primarily within the healthcare industry. The company was founded in September 2024 and had its initial public offering (IPO) on December 11, 2024, raising $230 million by selling units that consist of Class A ordinary shares and rights. As of March 18, 2025, the company had 23.84 million Class A shares and 5.75 million Class B shares outstanding. The filing discusses the organization’s acquisition strategy, focusing on businesses with solid management teams and significant growth potential. The document highlights that while it aims to establish a business combination with companies in healthcare services and technology, the search is not limited to these sectors. The management team is noted for its extensive experience in the healthcare industry and aims to leverage its network to capitalize on market opportunities. Future steps for the company include employing structured financial strategies for successful acquisitions.

Additional details:

Units Offered: 23000000


Ipo Date: 2024-12-11


Class A Shares Outstanding: 23840000


Class B Shares Outstanding: 5750000


Gross Proceeds: 230000000


Comments

No comments yet. Be the first to comment!